Human Chorionic Gonadotropin in Abnormal Pregnancy. Serum and Urinary Findings Using Various Immunoassay Techniques

1965 ◽  
Vol 44 (1) ◽  
pp. 32-44 ◽  
Author(s):  
Sam Brody ◽  
Gun Carlström
2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
LaToya R. Walker ◽  
Brian Erler

A 35-year-old woman presented to the emergency room for the evaluation of failed surgical and medical management of a suspected ectopic pregnancy. When imaging studies were performed, she had lymphadenopathy and diffuse sclerosis of the osseous framework. Multiple biopsies were performed and revealed poorly differentiated metastatic carcinoma with signet ring features. Esophagogastroduodenoscopy confirmed the findings of a Stage IV gastric adenocarcinoma. Signs and symptoms of gastric carcinoma are vague. However, to our knowledge, an elevation in human chorionic gonadotropin (hCG) is not an associated finding. Persistence of hCG has many causes from abnormal pregnancy to menopause and other forms of cancer.


Author(s):  
Hextan Y.S. Ngan ◽  
Karen K.L. Chan ◽  
Siew-Fei Ngu

Gestational trophoblastic disease (GTD) arises from an abnormal pregnancy which can subsequently develop into a neoplastic lesion and cancer. The most common abnormal pregnancy preceding GTD is usually benign. Molar pregnancy histologically is classified into partial and complete mole. The malignant histological types include choriocarcinoma, placental site trophoblastic tumour, and epithelioid trophoblastic tumour. The presence of abnormal proliferating trophoblastic tissues can be detected by serum human chorionic gonadotropin assays. Hence, a disease entity without histology but characterized by a persistently elevated serum human chorionic gonadotropin concentration after molar or normal pregnancy is named gestational trophoblastic neoplasia and forms part of the GTD spectrum where treatment is required. Treatment of the malignant form of GTD is mostly by chemotherapy with good prognosis.


1998 ◽  
Vol 37 (08) ◽  
pp. 297-298 ◽  
Author(s):  
A. Özet ◽  
A. Arpaci ◽  
S. Kömiircü ◽  
G. Üçkaya

Summary50 years old man suffering from primary lung adenocarcinoma presented with high levels of both beta subunit human chorionic gonadotropin (βHCG) and cancer antigen 15-3 (CA 15-3) in the absence of elevated carcinoembrionic antigen (CEA), alfa fetoprotein (AFP) and carbohydrate antigen 19-9 (CA 19-9). Although βHCG or CA 15-3 high levels were reported in adenocarcinoma of lung, this is the first report of a patient with high levels of both markers.


1985 ◽  
Vol 110 (1_Suppla) ◽  
pp. S106-S107
Author(s):  
K. KATO ◽  
A. MUKHOPADHYAY ◽  
H. G. BOHNET

1984 ◽  
Vol 104 (4_Supplb) ◽  
pp. S68-S69
Author(s):  
K. KATO ◽  
P. MANJUNATH ◽  
M. R. SAIRAM

Sign in / Sign up

Export Citation Format

Share Document